Nature's Sunshine Products reported second quarter 2026 net sales of $117.0 million, a 2% increase from the prior year period, with gross profit margin expanding to 73.7%. GAAP diluted earnings per share declined to $0.19 from $0.28 in the same quarter last year. The company lowered its full-year 2026 net sales guidance to a range of $490 million to $500 million and adjusted EBITDA guidance to $48 million to $52 million, citing foreign headwinds and softness in China. Additionally, the Board appointed Ruth Perkins as Executive Vice President and Chief Financial Officer, effective September 1, 2026. Nature’s Sunshine Products is a global manufacturer and distributor of herbal and nutritional supplements operating via direct selling.